Variants in AGTR2 gene in Maya people with COVID-19

Armando Totomoch-Serra; Miriam Givisay Domínguez-Cruz; C Manterola; Maria de Lourdes Muñoz

doi:10.1016/j.gene.2021.145794

Variants in AGTR2 gene in Maya people with COVID-19

Gene. 2021 Aug 30:795:145794. doi: 10.1016/j.gene.2021.145794. Epub 2021 Jun 24.

Authors

Armando Totomoch-Serra¹, Miriam Givisay Domínguez-Cruz², C Manterola³, Maria de Lourdes Muñoz⁴

Affiliations

¹ Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico; PhD Program in Medical Sciences, Universidad de La Frontera, Chile.
² Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
³ PhD Program in Medical Sciences, Universidad de La Frontera, Chile.
⁴ Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Electronic address: lmunoz@cinvestav.mx.

No abstract available

Keywords: AGTR2 gene; Angiotensin II Receptor Type 2; C21 drug; Covid-19; Diabetes mellitus; Maya population; Mexico; Pilot GWAS study; SARS-CoV-2; Single nucleotide polymorphism; Yucatan.

Publication types

Letter

MeSH terms

COVID-19 / genetics*
Diabetes Mellitus, Type 2 / genetics*
Genetic Predisposition to Disease
Humans
Indigenous Peoples / genetics
Mexico
Polymorphism, Single Nucleotide*
Receptor, Angiotensin, Type 2 / genetics*

Substances

AGTR2 protein, human
Receptor, Angiotensin, Type 2